Excerpt: On February 26, 2014, CMS Principal Deputy Administrator Jonathan Blum testified before the Committee that he was not aware that the Office of the Inspector General for the Department of Health and Human Services (OIG) and others had publicly stated that CMS does not have the legal authority to interfere in the negotiations between drug plans and pharma
Underscoring Commitment to Free and Open Internet, Subcommittee Continues Robust Oversight of Latest Administration ProposalApril 2, 2014 | Press Release
WASHINGTON, DC – The Subcommittee on Communications and Technology, chaired by Rep.
WASHINGTON, DC – The House Energy and Commerce Subcommittees on Energy and Power and Environment and the Economy today held a joint hearing to review the Environmental Protection Agency’s Fiscal Year 2015 budget request.
FDA Testimony Raises More Concerns Regarding Who Was Involved in Proposal, And Who Wasn’t
WASHINGTON, DC – The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), today held a hearing with General Motors CEO Mary Barra and National Highway Traffic Safety Administration Acting Administrator David Friedman to investigate the GM ignition switch recall and why it took over a decade to announce the recall after red flags and warning signs first surfaced.
The Subcommittee on Commerce, Manufacturing, and Trade, chaired by Rep. Lee Terry (R-NE), has scheduled a hearing for Tuesday, April 8, 2014, at 10:00 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Trolling for a Solution: Ending Abusive Patent Demand Letters.” Witnesses to be announced.